My wife is a nurse practitioner. It is mandated that all medical professionals take a certain amount of continuing education credits (called CME's) every 2-3 years or lose their license. She just got the following for a psoriasis CME being sponsored by Lily and Novartis. I can't help but think at some point our fav MMJ company should be putting out these CME's to med professionals to get the word out. I know they would not be able to prescribe, but at least they would be able to suggest patients try the creme, much like they suggest patients use calamine lotion or take an aspirin. I may be getting a bit ahead of myself here, and their focus should be on getting the product to market, but interesting nonetheless. Below is the email she got for the CME:
Psoriasis | Free CME
Physicians — maximum of .75 AMA PRA Category 1 Credits™
Improving Outcomes for Patients With Moderate to Severe Psoriasis
Click here to go directly to this activity
Find more CME-certified activities at freeCME.com®
Target Audience:
This activity is intended for dermatologists, internists, family physicians, nurse practitioners, physician assistants, pharmacists, and other healthcare providers involved in the care of patients with moderate to severe psoriasis.
Program Overview:
Topics covered include:
Long-term Safety of Biologics
Key Comorbidities: Managing Cardiovascular Risk
Key Comorbidities: Managing Depression
Patient-Reported Outcomes and Assessment of Severity
Sponsors:
Jointly provided by Boston University School of Medicine and Clinical Care Options, LLC.
Grantor:
This activity is supported by independent educational grants from Lilly USA, LLC. and Novartis Pharmaceuticals Corporation.
Learning Objectives:
Upon completion of this activity, participants should be better able to:
Integrate patient-reported outcomes and validated assessment tools into the assessment and management of patients with psoriasis in order to optimize clinical response and symptom improvement
Routinely incorporate cardiovascular risk assessment and management into the care of patients with psoriasis
Assess new and emerging clinical efficacy and safety data for currently available and novel agents in order to formulate appropriate treatment plans for patients with moderate to severe psoriasis
Credits Available:
Physicians — maximum of 0.75 AMA PRA Category 1 Credits™
All other healthcare professionals completing this course will be issued a statement of participation.
Faculty:
M Alan Menter, MD
Chairman of Dermatology
Baylor University Medical Center at Dallas
Dallas, Texas
Physician Continuing Medical Education
Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and Clinical Care Options, LLC. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation:
Boston University School of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Click here to go directly to this activity
Find more CME-certified activities at freeCME.com®
Copyright © 2017. All rights reserved.
Our mailing address is:
Relias Learning
111 Corning Road, Suite 250
Cary, North Carolina 27518
AI
